CRO

West Pharma moving away from CMO biz; Catalent replacing bioreactors for biologics production;

> West Pharmaceutical ($WST) is sticking with its plan to transition away from contract manufacturing, eyeing long-term profits from proprietary drugs. Story

> Catalent has replaced all of the stainless-steel bioreactors at one of its biologics facilities with single-use devices, saying the change has increased speed, flexibility and cost efficiency. News

> Cardiac testing laboratory cardioCORE Lab has been acquired by CardioNet, a heart diagnostic firm, for $23.5 million. Release

> French CRO Quinten is rapidly growing thanks to novel approach to data mining, breaking trial data up into patient subgroups to better predict outcomes in future studies. Article